Frontal Alpha Asymmetry and Its Modulation by Monoaminergic Neurotransmitters in Depression

Area of Science:

• Neuroscience
• Psychiatry
• Biomarkers

Background:

• Frontal alpha asymmetry (FAA) measures frontal cortex activation lateralization using EEG.
• Traditionally, greater FAA is linked to positive affect and reduced Major Depressive Disorder (MDD) risk.
• However, conflicting findings exist regarding FAA patterns in MDD.

Purpose of the Study:

• To review the literature on frontal alpha asymmetry (FAA) in Major Depressive Disorder (MDD).
• To explore the relationship between FAA and monoaminergic neurotransmitter systems.
• To propose how these interactions may inform MDD subtypes and treatments.

Main Methods:

• Literature review of studies on FAA in MDD.
• Examination of research on FAA and monoamine systems (serotonin, norepinephrine).
• Synthesis of findings to propose a theoretical model.

Main Results:

• Evidence suggests MDD is not consistently characterized by reduced FAA (left frontal hypoactivation).
• Serotonin and norepinephrine may differentially modulate FAA.
• Serotonin may promote right frontal activation, while norepinephrine may favor left frontal activation.

Conclusions:

• The relationship between FAA and MDD is complex and not fully explained by the traditional hypothesis.
• Differential effects of serotonin and norepinephrine on FAA could underlie MDD heterogeneity.
• Understanding these neurochemical-EEG interactions may lead to targeted pharmacologic treatments for MDD subtypes.